• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.减毒黄病毒疫苗诱导的 T 细胞反应具有特异性,与其他黄病毒种属表现出有限的交叉反应性。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.
2
Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.登革热和 Zika 病毒的交叉反应性 T 细胞免疫:疫苗开发的新见解。
Front Immunol. 2019 Jun 11;10:1316. doi: 10.3389/fimmu.2019.01316. eCollection 2019.
3
Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.鉴定抗前膜抗体作为血清复合物特异性标志物以区分寨卡病毒、登革热病毒和西尼罗河病毒感染
J Virol. 2021 Sep 9;95(19):e0061921. doi: 10.1128/JVI.00619-21.
4
Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model.黄病毒交叉保护机制在小鼠模型中的研究。
Viruses. 2024 May 24;16(6):836. doi: 10.3390/v16060836.
5
A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.植物源疫苗可预防小鼠感染致死性西尼罗河病毒,而不增强寨卡病毒或登革热病毒的感染力。
Vaccine. 2018 Mar 27;36(14):1846-1852. doi: 10.1016/j.vaccine.2018.02.073. Epub 2018 Feb 26.
6
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.先前登革热病毒感染会影响人体对寨卡病毒的 T 细胞免疫反应。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01469-17. Print 2017 Dec 15.
7
Human CD4 T Cell Responses to an Attenuated Tetravalent Dengue Vaccine Parallel Those Induced by Natural Infection in Magnitude, HLA Restriction, and Antigen Specificity.人类CD4 T细胞对一种减毒四价登革热疫苗的反应在强度、HLA限制和抗原特异性方面与自然感染所诱导的反应相似。
J Virol. 2017 Feb 14;91(5). doi: 10.1128/JVI.02147-16. Print 2017 Mar 1.
8
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.预先存在的日本脑炎病毒免疫力改变了对寨卡病毒灭活疫苗的 CD4 T 细胞反应。
Front Immunol. 2021 Feb 24;12:640190. doi: 10.3389/fimmu.2021.640190. eCollection 2021.
9
Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.泰国高通量中和测定法检测黄病毒中和抗体的血清流行率:2012 年之前寨卡病毒的地方性流行
mSphere. 2021 Aug 25;6(4):e0033921. doi: 10.1128/mSphere.00339-21. Epub 2021 Jul 14.
10
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection.用登革病毒E蛋白结构域I/II而非结构域III进行DNA免疫,会增强寨卡病毒、西尼罗河病毒和黄热病病毒的感染。
PLoS One. 2017 Jul 25;12(7):e0181734. doi: 10.1371/journal.pone.0181734. eCollection 2017.

引用本文的文献

1
Pre-existing YFV-17D immunity mediates T cell cross-protection against dengue virus serotype 2 infection in mice.预先存在的黄热病病毒17D免疫力介导小鼠T细胞对登革病毒2型感染的交叉保护作用。
Commun Biol. 2025 Sep 2;8(1):1334. doi: 10.1038/s42003-025-08793-3.
2
Human T Cell Responses to Flavivirus Vaccines.人类T细胞对黄病毒疫苗的反应。
Eur J Immunol. 2025 Aug;55(8):e70027. doi: 10.1002/eji.70027.
3
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells.高度保守的β冠状病毒序列被人类T细胞广泛识别。
Cell. 2025 Jul 30. doi: 10.1016/j.cell.2025.07.015.
4
"Silent messengers of chaos: unveiling the dual threat of immune infiltrates in Japanese encephalitis virus neuroinflammatory storm".沉默的混乱使者:揭示日本脑炎病毒神经炎症风暴中免疫浸润的双重威胁
Virol J. 2025 May 31;22(1):173. doi: 10.1186/s12985-025-02805-8.
5
Natural fatal infection of Tembusu virus in bottlenose dolphins in Thailand.泰国宽吻海豚感染坦布苏病毒的自然致死性感染
Sci Rep. 2025 Mar 22;15(1):9917. doi: 10.1038/s41598-025-93477-5.
6
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort.蜱传脑炎、日本脑炎和黄热病病毒疫苗单剂及联合接种后的抗原特异性T细胞反应:一项开放标签、非随机临床试验队列的结果
PLoS Negl Trop Dis. 2025 Feb 28;19(2):e0012693. doi: 10.1371/journal.pntd.0012693. eCollection 2025 Feb.
7
Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans.疫苗诱导的T细胞反应在无中和抗体的情况下控制人类黄病毒属病毒攻击感染。
Nat Microbiol. 2025 Feb;10(2):374-387. doi: 10.1038/s41564-024-01903-7. Epub 2025 Jan 10.
8
Targets of influenza human T-cell response are mostly conserved in H5N1.甲型流感病毒H5N1亚型中人类T细胞应答的靶点大多是保守的。
mBio. 2025 Feb 5;16(2):e0347924. doi: 10.1128/mbio.03479-24. Epub 2024 Dec 23.
9
Regional Variation of the CD4 and CD8 T Cell Epitopes Conserved in Circulating Dengue Viruses and Shared with Potential Vaccine Candidates.循环登革热病毒中和表位和潜在候选疫苗的 CD4 和 CD8 T 细胞表位的区域差异。
Viruses. 2024 May 5;16(5):730. doi: 10.3390/v16050730.
10
Host immunity and vaccine development against Dengue virus.针对登革病毒的宿主免疫与疫苗研发
Infect Med (Beijing). 2022 Feb 6;1(1):50-58. doi: 10.1016/j.imj.2021.12.003. eCollection 2022 Mar.

本文引用的文献

1
A review of Dengvaxia®: development to deployment.登革热疫苗(Dengvaxia®):从研发到应用的综述。
Hum Vaccin Immunother. 2019;15(10):2295-2314. doi: 10.1080/21645515.2019.1658503. Epub 2019 Oct 7.
2
Is Dengvaxia a useful vaccine for dengue endemic areas?登革热疫苗对登革热流行地区有用吗?
BMJ. 2019 Oct 3;367:l5710. doi: 10.1136/bmj.l5710.
3
Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003.评估候选活病毒减毒登革热疫苗 TAK-003 诱导产生的细胞免疫的多样性和稳定性。
Front Immunol. 2019 Jul 31;10:1778. doi: 10.3389/fimmu.2019.01778. eCollection 2019.
4
Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses.描述登革热病毒特异性 CD4+ T 细胞反应的幅度和抗原特异性与 HLA-DP、DQ 和 DRB3/4/5 的相关性。
Front Immunol. 2019 Jul 5;10:1568. doi: 10.3389/fimmu.2019.01568. eCollection 2019.
5
Mouse Models of Heterologous Flavivirus Immunity: A Role for Cross-Reactive T Cells.异源黄病毒免疫的小鼠模型:交叉反应性 T 细胞的作用。
Front Immunol. 2019 May 9;10:1045. doi: 10.3389/fimmu.2019.01045. eCollection 2019.
6
IEDB-AR: immune epitope database-analysis resource in 2019.IEDB-AR:2019 年免疫表位数据库分析资源。
Nucleic Acids Res. 2019 Jul 2;47(W1):W502-W506. doi: 10.1093/nar/gkz452.
7
Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.超越中和抗体水平:美国国立卫生研究院单价登革病毒疫苗诱导的抗体的表位特异性。
J Infect Dis. 2019 Jun 19;220(2):219-227. doi: 10.1093/infdis/jiz109.
8
Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles.登革热特异性 CD8+ T 细胞亚群表现出特异性的转录组和 TCR 谱。
J Clin Invest. 2019 Mar 18;129(4):1727-1741. doi: 10.1172/JCI123726.
9
Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8 T Cells.前沿:转录谱分析揭示了寨卡病毒特异性 CD8 T 细胞的多功能和细胞毒性抗病毒反应。
J Immunol. 2018 Dec 15;201(12):3487-3491. doi: 10.4049/jimmunol.1801090. Epub 2018 Nov 9.
10
The Immune Epitope Database (IEDB): 2018 update.免疫表位数据库(IEDB):2018 年更新。
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343. doi: 10.1093/nar/gky1006.

减毒黄病毒疫苗诱导的 T 细胞反应具有特异性,与其他黄病毒种属表现出有限的交叉反应性。

T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.

机构信息

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.

Saint Louis University, Saint Louis, Missouri, USA.

出版信息

J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.00089-20.

DOI:10.1128/JVI.00089-20
PMID:32132233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7199411/
Abstract

Members of the flavivirus genus share a high level of sequence similarity and often circulate in the same geographical regions. However, whether T cells induced by one viral species cross-react with other related flaviviruses has not been globally addressed. In this study, we tested pools of epitopes derived from dengue (DENV), Zika (ZIKV), Japanese encephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by intracellular cytokine staining (ICS) using peripheral blood mononuclear cells (PBMCs) of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccine. CD8 T cell responses recognized epitopes from multiple flaviviruses; however, the magnitude of cross-reactive responses was consistently severalfold lower than those to the autologous epitope pools and was associated with lower expression of activation markers such as CD40L, CD69, and CD137. Next, we characterized the antigen sensitivity of short-term T cell lines (TCL) representing 29 different individual epitope/donor combinations. TCL derived from DENV monovalent vaccinees induced CD8 and CD4 T cells that cross-reacted within the DENV serocomplex but were consistently associated with >100-fold-lower antigen sensitivity for most other flaviviruses, with no cross-recognition of YFV-derived peptides. CD8 and CD4 TCL from YF17D vaccinees were associated with very limited cross-reactivity with any other flaviviruses and in five out of eight cases >1,000-fold-lower antigen sensitivity. Overall, our data suggest limited cross-reactivity for both CD4 and CD8 T cell responses between flaviviruses and have implications for understanding immunity elicited by natural infection and strategies to develop live attenuated vaccines against flaviviral species. The envelope (E) protein is the dominant target of neutralizing antibodies for dengue virus (DENV) and yellow fever virus (YFV). Accordingly, several DENV vaccine constructs use the E protein in a live attenuated vaccine format, utilizing a backbone derived from a heterologous flavivirus (such as YF) as a delivery vector. This backbone comprises the nonstructural (NS) and capsid (C) antigens, which are dominant targets of T cell responses. Here, we demonstrate that cross-reactivity at the level of T cell responses among different flaviviruses is very limited, despite high levels of sequence homology. Thus, the use of heterologous flavivirus species as a live attenuated vaccine vector is not likely to generate optimal T cell responses and might thus impair vaccine performance.

摘要

黄病毒属的成员具有高度的序列相似性,通常在同一地理区域内传播。然而,一种病毒诱导的 T 细胞是否与其他相关的黄病毒发生交叉反应尚未得到全球关注。在这项研究中,我们通过使用来自自然感染登革热(DENV)或接种 DENV(TV005)或黄热病 17D 疫苗的个体外周血单核细胞(PBMC)进行细胞内细胞因子染色(ICS),测试了来自登革热、寨卡、日本脑炎、西尼罗河和黄热病病毒的表位池。CD8 T 细胞反应识别来自多种黄病毒的表位;然而,交叉反应性反应的幅度始终比自身表位池低几个数量级,并且与较低的活化标志物如 CD40L、CD69 和 CD137 的表达相关。接下来,我们使用代表 29 种不同个体表位/供体组合的短期 T 细胞系(TCL)来表征抗原敏感性。来自 DENV 单价疫苗接种者的 TCL 诱导了 CD8 和 CD4 T 细胞,这些细胞在 DENV 血清型内发生交叉反应,但与大多数其他黄病毒的抗原敏感性始终低 100 倍以上,对黄热病衍生肽没有交叉识别。来自黄热病 17D 疫苗接种者的 CD8 和 CD4 TCL 与其他任何黄病毒的交叉反应性非常有限,在八种情况下有五种抗原敏感性低 1000 倍以上。总体而言,我们的数据表明 CD4 和 CD8 T 细胞反应之间对黄病毒的交叉反应性有限,这对理解自然感染引起的免疫和开发针对黄病毒的活减毒疫苗的策略具有重要意义。包膜(E)蛋白是登革热病毒(DENV)和黄热病病毒(YFV)中和抗体的主要靶标。因此,几种 DENV 疫苗构建体使用 E 蛋白作为活减毒疫苗的形式,利用来自异源黄病毒(如 YF)的骨架作为递送载体。该骨架包含非结构(NS)和衣壳(C)抗原,这些抗原是 T 细胞反应的主要靶标。在这里,我们证明尽管存在高度的序列同源性,但不同黄病毒之间的 T 细胞反应的交叉反应性非常有限。因此,使用异源黄病毒作为活减毒疫苗载体不太可能产生最佳的 T 细胞反应,因此可能会损害疫苗的性能。